Liminal BioSciences LMNL

$ 8.5 0.0%

Quarterly report 2022-Q2
added 08-10-2022

Liminal BioSciences Balance Sheet 2011-2024 | LMNL

Annual Balance Sheet Liminal BioSciences

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-4.38 M	-22.5 M	120 M	65.9 M	21.3 M	-6.78 M	-3.3 M	-4.53 M	7.01 M	4.6 M
Long Term Debt	-	40.5 M	38.6 M	124 M	85.8 M	43.3 M	22.5 M	23.8 M	6.4 M	3.4 M	3.4 M
Long Term Debt Current	-	6.95 M	8.29 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	79 M	31.6 M	124 M	126 M	101 M	88.1 M	95.5 M	4.7 M	3.3 M	5.3 M
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	103 M	62.9 M	159 M	162 M	133 M	102 M	133 M	29.5 M	16.4 M	17.1 M
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-1.09 B	-871 M	-660 M	-468 M	-359 M	-260 M	-236 M	-256 M	-238 M	-239 M
Total Assets	-	118 M	165 M	103 M	284 M	265 M	215 M	203 M	49.9 M	23 M	8.7 M
Cash and Cash Equivalents	-	45.1 M	61.3 M	7.39 M	23.2 M	-	-	-	-	-	-
Book Value	-	15 M	102 M	-56.6 M	122 M	132 M	113 M	70 M	20.4 M	6.6 M	-8.4 M
Total Shareholders Equity	-	15 M	94.9 M	-63.1 M	143 M	-	-	-	-	-	-

All numbers in CAD currency

Quarterly Balance Sheet Liminal BioSciences

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	13.6 M	-	15.3 M	-	19.3 M	-	26.5 M	-	28.7 M	-	29.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	53.2 M	-	92.2 M	-	115 M	-	103 M	-	65.6 M	-	70.2 M	-	-	-	166 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-1.09 B	-	-1.07 B	-	-1.14 B	-	-1.09 B	-	-1.02 B	-	-967 M	-	-	-	-756 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	70.9 M	-	126 M	-	79.2 M	-	118 M	-	111 M	-	165 M	-	-	-	103 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	55.8 M	-	108 M	-	29.6 M	-	45.1 M	-	26 M	-	61.3 M	-	81 M	-	7.39 M	-	-	-	23.2 M	-	-	-	27.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	17.7 M	-	33.9 M	-	-36.3 M	-	15 M	-	45.5 M	-	94.9 M	-	-	-	-63.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	17.7 M	-	33.9 M	-	-36.3 M	-	15 M	-	45.5 M	-	94.9 M	-	134 M	-	-63.1 M	-	-	-	144 M	-	-	-	159 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in CAD currency